The use of synthetic analogues of Arg-Gly-Asp (RGD) and soluble receptor of tumor necrosis factor to prevent acute and chronic experimental liver injury.

por Bruck, R., Hershkoviz, R., Lider, O., Shirin, H., Aeed, H., Halpern, Z.
Publicado 1997